Atlas Trials

Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies

Clinical trial NCT05487651 · UNKNOWN

Trial details

NCT number
NCT05487651
Sponsor
Athenex, Inc.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
NHL, Relapsed, AdultB-cell LymphomaB-cell LeukemiaDLBCL - Diffuse Large B Cell LymphomaALL, Adult B CellALL, ChildhoodCLL/SLL
Start date
2022-10-01
Primary completion
2023-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.